Stockreport

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018 - ResearchAndMarkets.com

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF DUBLIN--(BUSINESS WIRE)-- The "Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's [Read more]